logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
12/03/2026
Palladium futures rose 1% intraday, now trading at $1,669.05 per ounce.
Latest
2 m ago
Failed sample delivery leads to a drop in stock price? Leontec Technology responds: We have never released any relevant information.
4 m ago
The German Institute for Economic Research (Ifo) stated that if energy prices remain high for a long period of time, the forecasted value of Germany's Gross Domestic Product (GDP) in 2026 may decrease by 0.2 percentage points.
4 m ago
The German Ifo Institute for Economic Research warns that long-term skyrocketing energy prices may lower the economic growth rate to 0.6% in 2026.
5 m ago
South Africa Statistics Bureau: South Africa's gold production in January decreased by 0.7% year-on-year.
6 m ago
Every AI express, Guojin Securities released a research report on March 12, giving Xintai (002294.SZ) a "buy" rating. The reasons for the rating mainly include: 1) Leading domestic heart and kidney metabolic syndrome, innovative transformation accelerating realization; 2) Nephrology, metabolism and orthopedic pipeline in full bloom, building a closed-loop chronic disease product; 3) Actively promoting the Hong Kong listing process, intending to empower innovative drug R&D through the construction of an "A+H" dual-capital platform. (Daily Economic News)
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.